StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO – Free Report) in a research report released on Sunday. The brokerage issued a sell rating on the medical equipment provider’s stock.
T2 Biosystems Price Performance
TTOO stock opened at $0.41 on Friday. The company’s 50-day moving average price is $0.52 and its 200 day moving average price is $2.41. T2 Biosystems has a 52 week low of $0.31 and a 52 week high of $6.95.
Institutional Trading of T2 Biosystems
A hedge fund recently bought a new stake in T2 Biosystems stock. Armistice Capital LLC acquired a new position in shares of T2 Biosystems, Inc. (NASDAQ:TTOO – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,658,000 shares of the medical equipment provider’s stock, valued at approximately $8,854,000. Armistice Capital LLC owned approximately 9.49% of T2 Biosystems at the end of the most recent quarter. Institutional investors and hedge funds own 23.18% of the company’s stock.
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Featured Stories
- Five stocks we like better than T2 Biosystems
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What is the S&P 500 and How It is Distinct from Other Indexes
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
